Posted on 2/22/21
The Johnson & Johnson Vaccine Has Competition in the Race to Treat New Strains
You might have thought the coronavirus vaccine race ended when Pfizer (NYSE:PFE) crossed the finish line first in December. But there's a new vaccine race underway. . . .
Posted on 2/22/21
Did Merck Make a Mistake With a Key FDA Filing?
Merck(NYSE:MRK) has won multiple U.S. Food and Drug Administration (FDA) approvals for its blockbuster cancer drug Keytruda. However, the big drugmaker seems to have run into . . .
Posted on 2/21/21
Citius Pharmaceuticals Closes $76.5M Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has closed its previously . . .
Posted on 2/19/21
AIkido Pharma Closes of $75 Million Bought Deal Offering of Common Stock
AIkido Pharma Inc. (Nasdaq: AIKI) today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price . . .
Posted on 2/19/21
Pfizer and BioNTech Launch Coronavirus Vaccine Study for Pregnant Women
With their BNT162b2 coronavirus vaccine now being distributed in major markets to inoculate the general public, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have moved to test it . . .
Posted on 2/19/21
Medicus Sciences Acquisition Corp. Closes $92M IPO
Medicus Sciences Acquisition Corp. announced today the closing of its initial public offering of 9,200,000 units, which included the full exercise of the underwriter's over-allotment option to . . .
Posted on 2/18/21
Talk To Your Doc About Cancer Screenings!
In conjunction with National Cancer Prevention Month this February and with declines in cancer screenings during
Posted on 2/18/21
Safest States During COVID-19 – Updated WalletHub Study
With only 5% of the population fully vaccinated against COVID-19 as of February 17, and vaccination being an essential component for full reopening of the economy, . . .
Posted on 2/18/21
Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results
PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December . . .
Posted on 2/18/21
Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected
The White House COVID-19 Response Team held a briefing on Wednesday where Joe Biden's recently appointed COVID-19 response coordinator, Jeff Zients, told the public some news . . .
Posted on 2/17/21
Citius Pharmaceuticals Prices $76.5 Million Registered Direct Offering
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into definitive . . .
Posted on 2/17/21
Caladrius Biosciences Closes $65 Million Registered Direct Offerings
BASKING RIDGE, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 2/17/21
ICV Partners Majority Investment in Total Access Urgent Care
ICV Partners, LLC, a leading investment firm focused on lower middle market companies in business services, consumer goods & services, food & beverage, and healthcare, announced . . .
Posted on 2/17/21
AIkido Pharma Announces $10 Million Bought Deal Offering Of Common Stock
AIkido Pharma Inc. (Nasdaq: AIKI) today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed . . .
Posted on 2/19/21
Citybiz Interview with Jim Rogers, CEO HealthConnect Networks and Mission Broadband
James E. Rogers, Jr. (Jim) is president of a growing family of telecommunications companies that include HealthConnect Networks
Posted on 2/17/21
Cedar Partners With Summit CityMD to Offer a New, Patient-Forward Financial Experience
Cedar's end-to-end patient engagement platform will give millions of patients across New York and New Jersey a consumer-centric digital experience at every step of the revenue . . .
Posted on 2/17/21
Royalty Pharma Reports Q4 2020 and Full-Year Results
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the fourth quarter of 2020 and introduced full-year . . .
Posted on 2/16/21
Galmed Pharmaceuticals Prices of $10 Million Public Offering of Ordinary Shares
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced the pricing of the underwritten public offering of 2,197,803 . . .
Posted on 2/16/21
Zoetis Reports Fourth Quarter and Full Year 2020 Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2020 and provided full year guidance for 2021.The . . .
Posted on 2/16/21
IQVIA Offers of Senior Notes
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc., intends to raise €1,450,000,000 in gross proceeds . . .
Posted on 2/16/21
Outlook Therapeutics Reports Financial Results for First Quarter Fiscal Year 2021 and Provides Corporate Update
MONMOUTH JUNCTION, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic . . .
Posted on 2/16/21
GBS Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing in the hands of patients . . .
Posted on 2/16/21
Hepion Pharmaceuticals Prices of Public Offering
EDISON, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the . . .
Posted on 2/16/21
Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna
Johnson & Johnson (NYSE:JNJ) announced late-stage results for its COVID-19 vaccine in late January. The immediate focus was on the vaccine's efficacy, which was markedly lower . . .
Posted on 2/16/21
What's the Outlook for Pfizer Stock?
Pfizer (NYSE:PFE) underperformed the S&P 500 in 2020. And in 2019. And in 2017. And in 2016. You probably noticed I skipped 2018 -- that was . . .
New York
